Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines (original) (raw)

• La Rue KE, Bradbury EM, Freyer JP. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts. Cancer Res 1998; 58(6): 1305–14.
  CAS Google Scholar
• Hamilton G. Multi-cellular spheroids as an in vitro tumor model. Cancer Lett 1998; 131(1): 29–34.
  Article PubMed CAS Google Scholar
• Santini MT, Rainaldi G. Three dimensional spheroid model in tumor biology Pathobiology 1999; 67: 148–57.
  Article PubMed CAS Google Scholar
• Rak J, Mitsuhashi Y, Erdos V et al. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression. J Cell Biol 1995; 131(6): 1587–98.
  Article PubMed CAS Google Scholar
• Desoize B, Gimonet D, Jawdiller JC. Cell Culture as spheroids: An approach to multi-cellular resistance. Anticancer Res 1988; 18(6A): 4147–58.
  Google Scholar
• Bates RC, Edwards NS, Yates JD. Spheroids and cell survival. Crit Rev Oncol Hematol 2000; 36(2–3): 61–74.
  PubMed CAS Google Scholar
• Rafstad EK, Wahl A, Davies C et al. Growth characteristics of human melanoma multi-cellular spheroids in liquid-overlay culture: Comparisons with the parent tumor xenografts. Cell Tissue Kinet 1986; 19: 205–16.
  Google Scholar
• Mueller-Klieser W. Three-dimensional cell cultures: From molecular mechanisms to clinical applications. Am J Pathol 1997; 273(4): C1109–23.
  CAS Google Scholar
• Lawlor ER, Schcel C, Irving J et al. Anchorage — independent multicellular spheroids as an in vitro model of growth signaling in Ewing tumors. Oncogene 2002; 21: 307–18.
  Article PubMed CAS Google Scholar
• Bartolazzi A, Peach R, Aruffo A et al. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994; 180: 53–66.
  Article PubMed CAS Google Scholar
• Tolg C, Hofmann M, Herrlich P et al. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21: 1225–9.
  PubMed CAS Google Scholar
• Screaton GR, Bell MV, Jackson DG et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160–4.
  Article PubMed CAS Google Scholar
• Koopman G, Hieder KH, Horst E et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the metastasis associated variant of CD44. J Exp Med 1993; 177: 879-904.
  Article Google Scholar
• Wielenga VJM, Heider KH, Offerhans JA et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754–6.
  PubMed CAS Google Scholar
• Kaufmann M, Heider KH, Sinn HP et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615–9.
  Article PubMed CAS Google Scholar
• Salmi M, Gron-Virta K, Sointu P et al. Regulated expression of exon v6 containing isoforms of cd44 in man: Down regulation during malignant transformation of tumors of squamo-cellular origin. J Cell Biol 1993; 122: 431-42.
  Article PubMed CAS Google Scholar
• Liu AY, Expression of CD44 in prostate cancer cells. Cancer Lett 1994; 76: 63–9.
  Article PubMed Google Scholar
• Seiter S, Schadendorf D, Harrmann K et al. Expression of CD44 variant isoforms in malignant melanoma. Clin Cancer Res 1996; 2: 447–56.
  PubMed CAS Google Scholar
• Manten-Horst E, Danen EH, Smit L et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995; 22(64): 182–8.
  Google Scholar
• Zhu Z, Sanchez-Sweatman O, Huang X et al. Anoikis and metastatic potential of Cloudman S91 melanoma cells. Cancer Res 2001; 61: 1707–16.
  PubMed CAS Google Scholar
• Coucke P, De leval L, Leyh P et al. Influence of laminin or fibroblasts upon colony formation in mouse by B16 melanoma cell spheroids: A morphometric analyses. In vivo 1992; 6(2): 119–24.
  PubMed CAS Google Scholar
• Raz A, Ben-ze'ev A. Modulation of the metastatic capability in B16 melanoma by cell shape. Science 1983; 221(4617): 1307–10.
  PubMed CAS Google Scholar
• StamenKovic I, Aruffok A, Amiot M et al. The hematopoietic and epithelial forms of CD44 are distinet polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10(2): 343–8.
  PubMed CAS Google Scholar
• Grimme HU, Termeer CC, Bennett KL et al. Colocalization of basic fibroblast growth factor and CD44 isoforms containing the variably spliced exon v3 (CD44v3) in normal skin and in epidermal skin cancers. Br J Dermatol 1999; 141(5): 824–32.
  Article PubMed CAS Google Scholar
• De Pauw-Gillet MC, Christiane Y, Foidarf JM et al. The mouse B16 melanoma in a 3-dimensional culture. Bull Assoc Anat (Nancy) 1986; 70(210): 21–4.
  CAS Google Scholar
• Perl AK, Wigenbus P, Dahl U et al. A causal role for E-cadherin in transition from adenoma to carcinoma. Nature 1998; 392: 190–3.
  Article PubMed CAS Google Scholar
• Vieminckx K, Vakaet L, Mareel M et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66(1): 107–19.
  Article Google Scholar
• Dorudi S, Shieffield JP, Poulsom R et al. E.Cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 1993; 142: 981–6.
  PubMed CAS Google Scholar
• Berx G, Cleton-Jansen AM, Strumane K et al. E.Cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extra-cellular domain. Oncogene 1996; 13: 1919-25.
  PubMed CAS Google Scholar
• Graff RJ, Gabrielson E, Fujii H et al. Methylation patterns of the cadherin 5' Cp9 island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275(4): 2727-32.
  Article PubMed CAS Google Scholar
• Pierceall WE, Woodard AS, Morrow JS et al. Frequent alterations in E.cadherin and alpha and beta catenin expression in human breast cancer. Oncogene 1995; 11(7): 1319–26.
  PubMed CAS Google Scholar
• Von Schilippe M, Marshell JF, Perry P et al. Functional Interaction between E-cadherin and αv containing integrin in carcinoma cells. J Cell Sci 2000; 113: 425–37.
  Google Scholar
• Silye R, Karyiannakis AJ, Syrigos KN et al. E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 1998; 186(4): 350–5.
  Article PubMed CAS Google Scholar
• Zhain XD, Hersey P. Expression of catenins and p120 cas in melanocytie nevi and cutaneous melanoma: Deficient α-catenin expression is associated with melanoma progression. Pathology 1999; 31(3): 239–46.
  Article Google Scholar
• Behren J, Von Kries JP, Kuhl M et al. Functional interaction of β-catenin with the transcription factor LEF-2. Nature 1996; 382(6592): 638–42.
  Article Google Scholar
• Molenaar M, Van de Weterin M, Oosterwegel M et al. XTCf-3 transcription factor mediates _β_-catenin induced axis formation in xenopus embryos. Cell 1996; 86(3): 391–9.
  Article PubMed CAS Google Scholar
• Rubinfeld B, Robbins P, EI-Gamil M et al. Stabilization of _β_-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790–2.
  Article PubMed CAS Google Scholar
• Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573–82.
  Article PubMed CAS Google Scholar
• Morgan DO. Principles of CDK regulation. Nature (London) 1995; 374: 131–4.
  Article CAS Google Scholar
• Croix BS, Florenes VA, Rak JW et al. Impact of the cyclin-dependent kinase inhibitor p27 kip1 on resistance of tumor cells to anticancer agents. Nature Med 1996; 2: 1204–10.
  Article Google Scholar